NCT05010109
- Conditions
- Locally Advanced Lung Non-Small Cell Carcinoma, Lung Diseases, Lung Neoplasms, +9 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Clinical trial condition
Locally Advanced Lung Non-Small Cell Carcinoma
Explore clinical trials studying Locally Advanced Lung Non-Small Cell Carcinoma. Study availability and eligibility vary by location and protocol.
14 public trials
6 recruiting studies
Locally Advanced Lung Non-Small Cell Carcinoma trial results
NCT07012031
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- University of California Davis Comprehensive Cancer Center Sacramento, California, United States
- Moffitt Cancer Center-International Plaza Tampa, Florida, United States
- Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
NCT05269381
- Conditions
- Adenocarcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, +168 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
NCT05624996
- Conditions
- Locally Advanced Lung Non-Small Cell Carcinoma, Lung Diseases, Lung Neoplasms, +7 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis Daphne, Alabama, United States
- Thomas Hospital Fairhope, Alabama, United States
NCT05136846
- Conditions
- Locally Advanced Lung Non-Small Cell Carcinoma, Lung Diseases, Lung Neoplasms, +13 more
- Locations
-
- City of Hope Duarte, California, United States
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT06361784
- Conditions
- Cardiotoxicity, Cardiovascular Diseases, Chemically-Induced Disorders, +7 more
- Locations
-
- Fondazione IRCCS Istituto Nazionale dei Tumori Milan, Italy
Active, not recruiting
Tocilizumab, Ipilimumab, and Nivolumab for the Treatment of Advanced Melanoma, Non-Small Cell Lung Cancer, or Urothelial Carcinoma
NCT04940299
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +72 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Ipilimumab and Nivolumab in Combination With Radiation Therapy in Treating Patients With Stage 2-3 Non-small Lung Cancer
NCT04013542
- Conditions
- ALK Gene Rearrangement, Bronchial Neoplasms, Carcinoma, Bronchogenic, +19 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Active, not recruiting
Brigatinib and Bevacizumab for the Treatment of ALK-Rearranged Locally Advanced, Metastatic, or Recurrent NSCLC
NCT04227028
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +17 more
- Locations
-
- City of Hope Medical Center Duarte, California, United States
- University of Colorado Cancer Center Aurora, Colorado, United States
- Northwestern University Chicago, Illinois, United States
- Rush University Medical Center Chicago, Illinois, United States
Active, not recruiting
Adaptive Radiation Planning for the Reduction of Radiation-Induced Toxicity in Patients With Stage II-IV Non-small Cell Lung Cancer
NCT04751747
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +20 more
- Locations
-
- Rutgers Cancer Institute of New Jersey New Brunswick, New Jersey, United States
- RWJBarnabas Health - Robert Wood Johnson University Hospital New Brunswick, New Jersey, United States